The number of inexplicable instances of hepatitis in the U. S. has climbed to 180 in 36 states, with a sixth child dying from the illness. The CDC’s Deputy Director for Infectious Diseases Jay Butler confirmed the new fatality during a press event Friday, saying it was confirmed by the agency on Thursday. He didn’t say where the death happened, therefore it remains unclear at the moment.
Butler stated that 15 of the 180 patients needed liver transplants in addition to the fatalities. The majority of the occurrences were in children less than 10 years old, with a median age of 2 years.
More than 600 instances have been reported in 31 nations, including 15 fatalities since the latest US figures were released. There is still a lot of confusion as to what is causing the infections, even after international health authorities have eliminated hepatitis viruses A through E.
While the CDC announced 109 new cases only two weeks ago, today’s total of 180 is a significant increase from that number, Butler cautioned that most of the 71 new cases were discovered in the last several weeks and months. According to Butler, just 7 percent of the 180 instances have happened in the previous two weeks.
Aside from the fact that the FDA is not seeing an overall rise in unexplained hepatitis cases, he was cautious not to state that the cases were part of an epidemic. There have been 180 instances during the previous seven months, and they have not been concentrated geographically or in time. More or less equally distributed throughout each of the 36 states, and monthly case totals have largely remained the same, according to Butler.
Since all nine original Alabama hepatitis patients screened negative for SARS-CoV-2 & had no record of SARS-CoV-2 infections, the CDC has thrown out any direct link between SARS-CoV-2 and hepatitis. SARS-CoV-2 antibodies, which would indicate a past infection, are currently being investigated in hepatitis patients.